The potential side effects of psychiatric medications are a critical consideration in patient care. The Journal of Clinical Psychiatry is dedicated to providing clinicians with comprehensive insights into the adverse effects associated with various treatments. Our expert editors curate content that delves into the physiological and psychological impacts of medications, from weight gain and sedation to mood changes and cognitive disturbances. As the field of psychopharmacology continues to evolve, our journal remains a trusted resource for understanding the balance between therapeutic benefits and potential risks.

Page 17

Recently published articles about Side Effects

PCC
Case Report

July 2, 2020

Serotonin syndrome appears in different gradations of severity, affecting recognition and reporting. Read this case report to find out more about this condition.
,
PCC
Case Report

June 11, 2020

Neuroleptic malignant syndrome (NMS) is often associated with use of typical antipsychotics, but antiepileptics have also been implicated. This report describes the case of an elderly man with schizophrenia...
, ,
PCC
Case Report

May 14, 2020

New-onset enuresis may be an underreported side effect of clozapine. The authors of this case report recommend directly questioning patients about clozapine-induced enuresis rather than vaguely inquiring about side...
,
PCC
Original Research

April 2, 2020

Depression has been associated with high mortality in people with diabetes. This study assessed the prevalence and associated factors of depression among diabetic outpatients in Ethiopia.
,
JCP
Original Research

March 31, 2020

Psychiatric patients are susceptible to cardiovascular disease (CVD), but this risk is poorly understood. This study compared CVD risk in psychiatric patients taking weight gain-inducing drugs with that in...
, , , et al
JCP
Original Research

March 24, 2020

How soon is too soon to look for metabolic syndrome in your patients with schizophrenia? This randomized open-label trial investigates 7 risk factors of 5 atypical and 2 typical...
, , , et al
PCC
Case Report

March 19, 2020

Could zolpidem induce long QT syndrome in some patients? Read this case report to find out more.
, , , et al
PCC
Original Research

February 6, 2020

Certain antipsychotics are known to increase weight and the risk for diabetes. Could some medications for diabetes promote not only glycemic control but also weight loss in patients taking...
, ,
JCP
Educational Activity

December 24, 2019

What steps do you take when patients exhibit tardive dyskinesia? Are you familiar with treatment guidelines and data on approved and non-approved strategies? Explore recommendations from Dr Daniel Kremens.
PCC
Case Report

December 19, 2019

Photophobia was once considered a rapidly reversible adverse effect of lithium mainly occurring in younger patients. This case describes a 50-year-old woman who experienced delayed-recovery lithium-induced photophobia and eye...
, ,
JCP
Educational Activity

December 17, 2019

Two medications are FDA-approved to treat tardive dyskinesia, and new long-term evidence has been reported. Follow along as expert Joseph P. McEvoy, MD, reviews the evidence.
PCC
Case Report

November 21, 2019

Levetiracetam is often prescribed by neurologists. This report sheds light on the psychiatric sequelae associated with levetiracetam while highlighting clinical correlates and management issues.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe